Literature DB >> 1651408

The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture.

S A Sedman1, M S Barbosa, W C Vass, N L Hubbert, J A Haas, D R Lowy, J T Schiller.   

Abstract

The wild-type E6 and E7 genes of human papillomavirus type 16 (HPV16) can cooperate to immortalize normal human keratinocytes in culture. The E6 open reading frame of HPV16 and other HPV types highly associated with cervical cancer has the potential of encoding both full-length E6 and two truncated E6* proteins, the latter being generated via splicing within the E6 open reading frame portion of the E6-E7 polycistronic transcript. Those types, such as HPV6, that are infrequently associated with cervical carcinoma lack the splice site and encode only a full-length E6. We have now found that, in addition to cooperating with E7 to immortalize keratinocytes, HPV16 E6 can induce anchorage-independent growth in NIH 3T3 cells and trans-activate the adenovirus E2 promoter. HPV6 E6 was also able to trans-activate the adenovirus E2 promoter, although it was inactive in both cell transformation assays. An HPV16 splice site mutant which expressed only the full-length HPV16 E6 was active in all three assays, indicating that the E6* proteins are not required for these activities. The plasmid which encodes the E6* proteins was inactive and did not potentiate the activity of the HPV16 splice site mutant. The mutation that prevented splicing in E6-E7 mRNA severely reduced the level of E7 protein and increased E6 protein. Taken together, the results suggest that the primary function of the splice within E6 is to facilitate the translation of E7 and reduce translation of full-length E6, rather than to generate biologically active E6* proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1651408      PMCID: PMC248945     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Inducible and constitutive enhancer domains in the noncoding region of human papillomavirus type 18.

Authors:  D Gius; S Grossman; M A Bedell; L A Laimins
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  The E6-E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 3T3 and rat-1 cells.

Authors:  M A Bedell; K H Jones; L A Laimins
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

3.  Potential metal-binding domains in nucleic acid binding proteins.

Authors:  J M Berg
Journal:  Science       Date:  1986-04-25       Impact factor: 47.728

4.  Helper-independent transformation by unintegrated Harvey sarcoma virus DNA.

Authors:  D R Lowy; E Rands; E M Scolnick
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

5.  Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization.

Authors:  A Mincheva; L Gissmann; H zur Hausen
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

6.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

7.  A simple method for site-directed mutagenesis using the polymerase chain reaction.

Authors:  A Hemsley; N Arnheim; M D Toney; G Cortopassi; D J Galas
Journal:  Nucleic Acids Res       Date:  1989-08-25       Impact factor: 16.971

8.  In vitro biological activities of the E6 and E7 genes vary among human papillomaviruses of different oncogenic potential.

Authors:  M S Barbosa; W C Vass; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

9.  The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene.

Authors:  K H Vousden; J Doniger; J A DiPaolo; D R Lowy
Journal:  Oncogene Res       Date:  1988-09

10.  The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A.

Authors:  W C Phelps; C L Yee; K Münger; P M Howley
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

View more
  64 in total

1.  Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes.

Authors:  M Hummel; J B Hudson; L A Laimins
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

Review 2.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

3.  In vitro expressed HPV 8 E6 protein does not bind p53.

Authors:  G Steger; H Pfister
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

4.  Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras.

Authors:  Kristi L Berger; Felicia Barriga; Michael J Lace; Lubomir P Turek; Gideon J Zamba; Frederick E Domann; John H Lee; Aloysius J Klingelhutz
Journal:  Virology       Date:  2006-08-30       Impact factor: 3.616

Review 5.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

Review 6.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

7.  Differential in vitro immortalization capacity of eleven (probable) [corrected] high-risk human papillomavirus types.

Authors:  Denise M Schütze; Peter J F Snijders; Leontien Bosch; Duco Kramer; Chris J L M Meijer; Renske D M Steenbergen
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

8.  Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16.

Authors:  L Sherman; R Schlegel
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

9.  Translation of the human papillomavirus type 16 E7 oncoprotein from bicistronic mRNA is independent of splicing events within the E6 open reading frame.

Authors:  S N Stacey; D Jordan; P J Snijders; M Mackett; J M Walboomers; J R Arrand
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Inhibition of p53 DNA binding by human papillomavirus E6 proteins.

Authors:  M S Lechner; L A Laimins
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.